Position in GRFS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$477,863
+$114,747 QoQ
Shares Held
59,584
+53.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 64.61742443314368.ToString("F0")%
Shared 0.ToString("F0")%
None 35.38257556685632.ToString("F0")%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Orion Porfolio Solutions, LLC holds $221,310,249 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
226,615 | $55,393,769 | |
| 2 | LLY |
ELI LILLY & Co
|
51,627 | $47,484,964 | |
| 3 | ABBV |
AbbVie Inc.
|
138,202 | $30,057,552 | |
| 4 | AZN |
Astrazeneca PLC
|
80,263 | $15,829,467 | |
| 5 | MRK |
Merck & Co., Inc.
|
124,118 | $14,930,153 | |
| 6 | PFE |
Pfizer Inc
|
446,491 | $12,537,466 | |
| 7 | AMGN |
Amgen Inc
|
27,190 | $9,566,800 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
68,638 | $9,566,077 |
All Filings in GRFS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $477,863 | 59,584 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $363,116 | 38,836 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $427,184 | 42,890 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $259,836 | 28,743 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $111,399 | 15,668 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $118,697 | 15,954 | Shares | Sole | 2025-08-01 | |
| 2023-06-30 | $93,688 | 10,228 | Shares | Sole | 2025-07-31 | |
| 2022-09-30 | $68,517 | 11,123 | Shares | Sole | 2022-11-01 | |
| No filing history on record for this holder in this stock. | ||||||